ArticleSkin health and disease2026

Real-world single-centre experience of bimekizumab in patients with psoriasis: a 16-week retrospective observational study.

Zekayi Kutlubay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.